
Nektar Therapeutics (Nasdaq: NKTR) today announced the promotion of Lorianne Masuoka, M.D. to Senior Vice President and Chief Medical Officer. Lorianne, who holds an M.D. from the University of California, Davis and completed her fellowship at the Yale School of Medicine, had been Vice President of Clinical Development at Nektar. Read more in the prnewswire
press release.
Recent Comments